* The information is not intended to be and does not constitute financial advice or any other recommendation of any sort offered or endorsed by Gate.io.
* This article may not be reproduced, transmitted or copied without referencing Gate.io. Contravention is an infringement of Copyright Act and may be subject to legal action.
Decentralized Science (DeSci) is becoming a crucial aspect of Web3 development, as it solves fundamental problems such as unequal research funding, intellectual property monopolies, and lack of transparency in scientific research. By leveraging DAO, IP-NFTs, and token economies, DeSci empowers scientific innovation, drives the real-world adoption of Web3, and accelerates progress toward fairer and more open research.
This report conducts a detailed backtest comparing the investment performance of Dollar-Cost Averaging (DCA) versus Buy-and-Hold strategies for BTC, ETH, SOL, GT, and their combinations in Gate.io investment products from September 1, 2021, to December 30, 2024. The report uses an example-based approach to demonstrate the calculation steps and core formulas for each strategy, accompanied by data tables for key periods.
DeSci (Decentralized Science) is becoming a hot topic in the blockchain industry, sparking widespread discussion, especially in the field of innovative drug funding. However, there is a significant mismatch between DeSci and the biopharmaceutical industry in terms of funding, timelines, and operational models, making integration highly challenging. This article provides an in-depth analysis of the current state, challenges, and potential development paths of DeSci in the innovative drug sector, including new models such as IP-NFTs, RWAs, and clinical data prediction.
* The information is not intended to be and does not constitute financial advice or any other recommendation of any sort offered or endorsed by Gate.io.
* This article may not be reproduced, transmitted or copied without referencing Gate.io. Contravention is an infringement of Copyright Act and may be subject to legal action.
Decentralized Science (DeSci) is becoming a crucial aspect of Web3 development, as it solves fundamental problems such as unequal research funding, intellectual property monopolies, and lack of transparency in scientific research. By leveraging DAO, IP-NFTs, and token economies, DeSci empowers scientific innovation, drives the real-world adoption of Web3, and accelerates progress toward fairer and more open research.
This report conducts a detailed backtest comparing the investment performance of Dollar-Cost Averaging (DCA) versus Buy-and-Hold strategies for BTC, ETH, SOL, GT, and their combinations in Gate.io investment products from September 1, 2021, to December 30, 2024. The report uses an example-based approach to demonstrate the calculation steps and core formulas for each strategy, accompanied by data tables for key periods.
DeSci (Decentralized Science) is becoming a hot topic in the blockchain industry, sparking widespread discussion, especially in the field of innovative drug funding. However, there is a significant mismatch between DeSci and the biopharmaceutical industry in terms of funding, timelines, and operational models, making integration highly challenging. This article provides an in-depth analysis of the current state, challenges, and potential development paths of DeSci in the innovative drug sector, including new models such as IP-NFTs, RWAs, and clinical data prediction.